Regulatory Obligations for Investigator-Sponsored Research This presentation reviews the responsibilities for IND sponsors and clinical investigators; summarizes the expectations for sponsor investigators; discusses the submission options that sponsors will face when submitting INDs and IDEs to FDA; reviews some suggestions for successful research; and finishes with a discussion of FDA inspection findings. (Javascript is required to view Mediasite content)